Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Hemihyperplasia-multiple lipomatosis syndrome

Diseases of the Skin and Subcutaneous Tissue

Hemihyperplasia-multiple lipomatosis syndrome is a cutaneous condition characterized by multiple lipomas together with asymmetric overgrowth, cutaneous capillary malformations and thickened plantar skin with prominent creases.

Facts
Classification
Body System
Integumentary System 1
ICD-10 Chapter
XII: Diseases of the Skin and Subcutaneous Tissue 1
Communicable or Non-communicable
Non-Communicable 2
Transmission Route
Non-Transmissible 2
Causative Agent
Causative Agent (category)
Genetic / Hereditary 3
Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XII
Quote, List of chapters, Chapter XII
Diseases of the skin and subcutaneous tissue
View the Source
2. Wikidata: Hemihyperplasia-multiple lipomatosis syndrome
WikidataWikidata P31/P279 (instance of / subclass of)
Quote, Wikidata P31/P279 (instance of / subclass of)
rare capillary malformation with associated anomalies; rare genetic bone disease; genetic skin vascular disorder; syndrome or malformation associated with head and neck malformations; skull cancer; malformation syndrome with hamartosis; skin tumor or hamartoma; rare genetic vascular tumor; overgrowt
View the Source
3. Monarch Disease Ontology (MONDO) via EMBL-EBI Ontology Lookup Service: hemihyperplasia-multiple lipomatosis syndrome
Monarch Disease Ontology (MONDO) via EMBL-EBI Ontology Lookup ServiceMONDO MONDO:0017177 definition: causative agent
Quote, MONDO MONDO:0017177 definition: causative agent
A rare, genetic overgrowth syndrome characterized by non- progressive, asymmetrical, moderate hemihyperplasia (frequently affecting the limbs) associated with slow growing, painless, multiple, recurrent, subcutaneous lipomatous masses distributed throughout entire body (in particular back, torso, extremities, fingers, axillae).
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.